Cheers! AI augments hearing aids with virtual microphones ‘mounted’ on the forehead

Amid the clinking, chattering and chortling of a cocktail party, wearers of hearing aids struggle to follow any one conversation. Help may be on the way in the form of hearing aids incorporating virtual sensing aided by deep learning, according to a study conducted at the University of Bern in Switzerland.

Most hearing aids and cochlear implants use several microphones situated alongside each other on the housing of the audio processors, Wilhelm Wimmer, PhD, and colleagues point out in a study now current in Hearing Research.

Their experimental approach delivers a more natural sound by correcting for the need to place microphones at impractical points like the forehead.

That’s what it would take to replicate an unassisted hearing experience by those with normal hearing, Wimmer and co-authors explain.

Their virtualized system estimates microphone signals using a deep neural network that doesn’t need to know how the actual microphones are arranged on real-world hearing aids and cochlear implants.  

Wimmer and colleagues tested the approach with objective measures as well as a subjective listening test with 20 participants.

The team found that the virtually sensed microphone signals “significantly improved speech quality, especially in cocktail party scenarios with low signal-to-noise ratios. … [H]earing aid or cochlear impant users might benefit from virtually sensed microphone signals, especially in challenging cocktail party scenarios.”

The study is available in full for free.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.